Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Zhen Yang, Ph.D. is a senior scientist of biopharmaceutics at Merck. Prior to joining Merck, Dr. Yang led a clinical bioanalytical lab as Supervisor at Texas Medical Toxicology for 1 year. Zhen obtained his Ph.D. at University of Houston focusing on oral drug absorption, metabolism, and related drug transporters. In his master program at Shanghai Institute of Pharmaceutical Industry, he worked on development of transdermal drug formulation. Zhen\s main research area is to support oral formulation development at various development stages. In addition, Zhen will lead and collaborate with colleagues in identifying and evaluating opportunities for alternate route of drug delivery in both drug discovery and late stage development.
Biopharmaceutical evaluation, metabolomics, drug delivery systems, Pharmacometabolomics, Clinical Studies
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals